PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Herceptin found to improve long-term survival of HER2-positive breast cancer patients

2014-12-15
(Press-News.org) VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute (NCI)-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients. The combined study was designed to determine the long-term safety and efficacy of the drug trastuzumab, which is commonly known as Herceptin and is primarily used alongside chemotherapy to treat HER2-positive breast cancer. The combined study focused on both the overall survival rates of patients up to ten years post-treatment as well as the known and potentially harmful side effects to the cardiac system.

Published in the Journal of Clinical Oncology, the study found that Herceptin, when added to chemotherapy, improved 10-year survival from 75 percent with chemotherapy alone to 84 percent with the addition of trastuzumab. Additionally, results also demonstrated continued improvement of survival without cancer recurrence--the 10-year disease-free survival rate increased from 62 percent to 74 percent with the addition of trastuzumab. Although heart problems are recognized side effects of Herceptin, the incidence rate of such events was found to be about 3 percent and the majority of those patients recovered from the initial effects.

"We have found that when Herceptin is used in combination with chemotherapy, a patient's survival is significantly improved," said Geyer, who serves as a senior scientific advisor to the NSABP and at Massey is the Harrigan, Haw, Luck Families Chair in Cancer Research, associate director for clinical research and member of the Developmental Therapeutics research program, as well as professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine. "There are minimal long-term side effects, and the likelihood of the cancer recurring is greatly reduced."

The study was designed to provide much needed long-term efficacy data on Herceptin--a proven effective treatment, but one without much information on the role it plays in patients' long-term survival. The study combines data from two trials: NSABP B-31, led by the National Surgical Adjuvant Breast and Bowel Project (NSABP), and NCCTG N9831, led by the North Central Cancer Treatment Group (NCCTG). Each trial was designed independently to analyze overall survival rates of patients with early-stage HER2-positive breast cancer. The study specifically addressed whether or not the patient experienced a cancer recurrence and if there were any harmful side effects that would diminish favorable treatment results.

The local principal investigator leading the NSABP B-31 trial at Massey was Harry Bear, M.D., Ph.D. Bear, who is the Dr. Walter Lawrence, Jr. Chair in Surgical Oncology, director of the Breast Health Center and medical director of the Clinical Trials Office at Massey, also serves on the Board of Directors of the NSABP Foundation, Inc.

Herceptin was approved by the Food and Drug Administration in 2006, based on the initial results of these two studies, as an adjuvant treatment for HER2-positive breast cancers, which test positive for the HER2 mutation and are often more aggressive than other types of breast cancers. HER2 - human epidermal growth factor receptor 2 - is a protein that plays a significant role in breast cancer. HER2 proteins are products of the HER2 gene and work to control the growth of healthy cells. If the proteins are overexpressed, or if the HER2 gene is amplified, the cells can grow uncontrollably and become cancerous. Approximately 15 to 20 percent of invasive breast cancers result from HER2 gene amplification or overexpression of the HER2 protein.

Additional trials are currently underway to try to improve patient outcomes by using Herceptin in combination with various other drugs that also specifically target breast cancers with overexpressed HER2 proteins. Other trials are investigating applications of Herceptin for different cancers. For example, one study is presently investigating whether or not patients with breast cancers with lower amounts of HER2 protein might also benefit from Herceptin's promising results.

INFORMATION:

This study was supported by NIH grants U10-CA25224 and CA129949; NSABP grants U10-CA12027, U10-CA69651, U10-CA37377 and U10-CA69974; by the Breast Cancer Research Foundation; and by grants 35-03 from Genentech. P.A.K. received research funding from Cancer and Leukemia Group B.

The full study is available online at: http://jco.ascopubs.org/content/early/2014/10/14/JCO.2014.55.5730.full.pdf



ELSE PRESS RELEASES FROM THIS DATE:

Switching to vehicles powered by electricity from renewables could save lives

2014-12-15
Driving vehicles that use electricity from renewable energy instead of gasoline could reduce the resulting deaths due to air pollution by 70 percent. This finding comes from a new life cycle analysis of conventional and alternative vehicles and their air pollution-related public health impacts, published Monday, Dec. 15, 2014, in the Proceedings of the National Academy of Sciences. The study also shows that switching to vehicles powered by electricity made using natural gas yields large health benefits. Conversely, vehicles running on corn ethanol or vehicles powered ...

Non-Gluten proteins identified as targets of immune response to wheat in celiac disease

2014-12-15
NEW YORK, NY (December 15, 2014)--Researchers at Columbia University Medical Center have found that, in addition to gluten, the immune systems of patients with celiac disease react to specific types of non-gluten protein in wheat. The results were reported online in the Journal of Proteome Research. Celiac disease, an autoimmune disorder that affects about 1 percent of the U.S. population, is triggered by the ingestion of wheat and related cereals in genetically susceptible individuals. The immune response results in inflammation and tissue damage in the small intestine, ...

Hidden movements of Greenland Ice Sheet, runoff revealed

Hidden movements of Greenland Ice Sheet, runoff revealed
2014-12-15
VIDEO: This animation (from March 2014) portrays the changes occurring in the surface elevation of the Greenland Ice Sheet since 2003 in three drainage areas: the southeast, the northeast and the... Click here for more information. For years NASA has tracked changes in the massive Greenland Ice Sheet. This week scientists using NASA data released the most detailed picture ever of how the ice sheet moves toward the sea and new insights into the hidden plumbing of melt water ...

Chapman University research on farmers' markets shows presence of Salmonella and E. coli

2014-12-15
ORANGE, Calif. - Researchers in Chapman University's Food Science Program and their collaborators at University of Washington have just published a study on the presence of Salmonella and E. coli on certain herbs sold at farmers' markets. The study focused on farmers' markets in Los Angeles and Orange counties in California, as well as in the Seattle, Washington, area. Specifically tested were samples of the herbs cilantro, basil and parsley. Of the 133 samples tested from 13 farmers' markets, 24.1 percent tested positive for E. coli and one sample tested positive for Salmonella. "While ...

Dartmouth researchers create 'green' process to reduce molecular switching waste

Dartmouth researchers create green process to reduce molecular switching waste
2014-12-15
HANOVER, N.H. - Dartmouth researchers have found a solution using visible light to reduce waste produced in chemically activated molecular switches, opening the way for industrial applications of nanotechnology ranging from anti-cancer drug delivery to LCD displays and molecular motors. The study appears in the Journal of the American Chemical Society. A PDF is available on request. Chemically activated molecular switches are molecules that can shift controllably between two stable states and that can be reversibly switched -- like a light switch -- to turn different ...

Seeing the forest for the trees

Seeing the forest for the trees
2014-12-15
The largest trees in a forest may command the most attention, but the smallest seedlings and youngest saplings are the ones that are most critical to the composition and diversity of the forest overall. While many people gaze up into the forest canopy, renowned scientist Joseph Connell has spent much of his career looking down quite closely at the forest understory. Connell, who is a professor emeritus in the Department of Ecology, Evolution and Marine Biology at the University of California at Santa Barbara, established one of the world's longest, in-depth ecological research ...

Christmas cracker pulling: How to send everyone home a winner

2014-12-15
According to experts' statistical analyses, if you're expecting 10 guests for dinner on Christmas day, 15 crackers--those festive cardboard tubes filled with a one-size-fits-no-one paper hat, a small toy, and a groan-inducing joke--should be enough to send everyone home happy. The experts came to their estimation by simulating 10,000 parties, with guest numbers ranging from 2 to 50. Their results are published in Significance. In the traditional approach, all dinner guests sit around the table, cross arms, and pull crackers with their two immediate neighbors. In this ...

Evidence of Viking/Norse metalworking in Arctic Canada

2014-12-15
A small stone container found by archaeologists a half-century ago has now been recognized as further evidence of a Viking or Medieval Norse presence in Arctic Canada during the centuries around 1000 A.D. Researchers reporting in the journal Geoarchaeology discovered that the interior of the container, which was found at an archaeological site on southern Baffin Island, contains fragments of bronze as well as small spherules of glass that form when rock is heated to high temperatures. The object is a crucible for melting bronze, likely in order to cast it into small tools ...

How blood parasites colonize and persist in small island bird populations

2014-12-15
A new study highlights the complex factors at play for parasites that infect animal populations residing on small islands. The findings are important for understanding colonization and extinction as drivers of island biogeography. Investigators who studied the mechanisms that contribute to colonization and persistence of avian malaria parasites in an island bird population found that increases in the prevalence and diversity of parasites were associated with episodes of offshore winds and less so with infected vagrant birds arriving from the mainland. "We were surprised ...

Do crows have an impact on the population of their prey?

2014-12-15
They steal, raid nests, and keep the company of witches, but the unpopular crow may not be as big a menace as people think. A new Ibis study has found that crows--along with their avian cousins the magpie and the raven--have surprisingly little impact on the abundance of other bird species. Collectively known as corvids, these birds are in fact being menaced by mankind in the mistaken belief that removing them is good for conservation. "These results have big implications for the likely benefits of corvid control," said senior author Dr. Arjun Amar. "They suggest that ...

LAST 30 PRESS RELEASES:

Why some brains switch gears more efficiently than others

UVA’s Jundong Li wins ICDM’S 2025 Tao Li Award for data mining, machine learning

UVA’s low-power, high-performance computer power player Mircea Stan earns National Academy of Inventors fellowship

Not playing by the rules: USU researcher explores filamentous algae dynamics in rivers

Do our body clocks influence our risk of dementia?

Anthropologists offer new evidence of bipedalism in long-debated fossil discovery

Safer receipt paper from wood

Dosage-sensitive genes suggest no whole-genome duplications in ancestral angiosperm

First ancient human herpesvirus genomes document their deep history with humans

Why Some Bacteria Survive Antibiotics and How to Stop Them - New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes”

UCLA study links scar healing to dangerous placenta condition

CHANGE-seq-BE finds off-target changes in the genome from base editors

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 2, 2026

Delayed or absent first dose of measles, mumps, and rubella vaccination

Trends in US preterm birth rates by household income and race and ethnicity

Study identifies potential biomarker linked to progression and brain inflammation in multiple sclerosis

Many mothers in Norway do not show up for postnatal check-ups

Researchers want to find out why quick clay is so unstable

Superradiant spins show teamwork at the quantum scale

Cleveland Clinic Research links tumor bacteria to immunotherapy resistance in head and neck cancer

First Editorial of 2026: Resisting AI slop

Joint ground- and space-based observations reveal Saturn-mass rogue planet

Inheritable genetic variant offers protection against blood cancer risk and progression

Pigs settled Pacific islands alongside early human voyagers

A Coral reef’s daily pulse reshapes microbes in surrounding waters

EAST Tokamak experiments exceed plasma density limit, offering new approach to fusion ignition

Groundbreaking discovery reveals Africa’s oldest cremation pyre and complex ritual practices

First breathing ‘lung-on-chip’ developed using genetically identical cells

How people moved pigs across the Pacific

Interaction of climate change and human activity and its impact on plant diversity in Qinghai-Tibet plateau

[Press-News.org] Herceptin found to improve long-term survival of HER2-positive breast cancer patients